Monsanto Co
Article Abstract:
Share price for Monsanto Co was reduced 5-5/8 for the trading week ended June 5, 1992 as a result of earnings estimate reductions by a number of analysts. Paul Leming of Kidder, Peabody alleged that marketing costs for Monsanto's G.D. Searle division's three newest products destroyed the parent company's 1992 and 1993 profits and would result in a 25% increase in Searle's GS&A. As such, Leming has lowered his 1992 Monsanto estimate to $4.75 a share from $5.50 and his 1993 projection to $5.25 from $6.20.
Publication Name: The Insiders' Chronicle
Subject: Business
ISSN: 0162-5152
Year: 1992
User Contributions:
Comment about this article or add new information about this topic:
Matrix Pharmaceutical Inc
Article Abstract:
Stock analyst Jeffrey B. Swarz gives a Strong Buy rating for Matrix Pharmaceutical Inc stock. He states that the undervalued company is better than other pharmaceutical firms because of the efficacy of its drugs and its highly promising technology. An example of this is the drug used in genital wart cure which produced a 76% reduction rate. Two other studies resulted in an 88% and 86% effectiveness rate in the treatment of psoriasis and basal cell carcinoma, respectively.
Publication Name: The Insiders' Chronicle
Subject: Business
ISSN: 0162-5152
Year: 1992
User Contributions:
Comment about this article or add new information about this topic:
Circuit City Stores Inc
Article Abstract:
Circuit City Stores VP William Ligon purchased 5,100 shares on Apr 10, 1992 at 34-3/8-35, raising his stake to 13,850 in the consumer electronics and home appliances retailer. Ten days later, Dir Alan Wurtzel and VP John Froman unloaded 8,400 shares at the same price. The company posted increases in sales and profits of 18% and 38% respectively for FY 1991. The company pays $0.10 per share on its 47 million shares outstanding.
Publication Name: The Insiders' Chronicle
Subject: Business
ISSN: 0162-5152
Year: 1992
User Contributions:
Comment about this article or add new information about this topic: